Efficacy and safety of neoadjuvant immunotherapy in patients with microsatellite instability-high gastrointestinal malignancies: A case series

Ejso3.80
Volume: 46, Issue: 10, Pages: e33 - e39
Published: Oct 1, 2020
Abstract
Introduction null Immune checkpoint inhibitors (ICIs) have been approved for the late-line treatment of unresectable gastrointestinal tumors, but their efficacy and safety in the neoadjuvant setting have not been described. Whether dMMR/MSI-H populations benefit from preoperative ICIs plus surgery remains undefined. null null null Materials and methods null Six consecutive patients managed at our institution received neoadjuvant ICIs and surgery...
Paper Details
Title
Efficacy and safety of neoadjuvant immunotherapy in patients with microsatellite instability-high gastrointestinal malignancies: A case series
Published Date
Oct 1, 2020
Journal
Volume
46
Issue
10
Pages
e33 - e39
Citation AnalysisPro
  • Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
  • Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.